Interleukin-12 Is Associated with Rheumatoid Factor and Interferon-γ, but Not with Disease Activity, in Patients with Rheumatoid Arthritis
Diagnostics · 04.11.2026 · 16 (21) · 3643
DOI: 10.3390/diagnostics16213643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 04.11.2026. Verfasst von Iván Ferraz-Amaro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of La Laguna (ULL), 38071 Tenerife, Spain. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Spanish Red de Investigación RICORS, European Union.
Abstract (Originalsprache)
Background
IL-12 is a proinflammatory cytokine produced mainly by activated dendritic cells and macrophages that drives the differentiation of naïve T cells into Th1 cells and stimulates interferon-γ production by natural killer and T cells, thereby linking innate and adaptive immunity. Ultrasensitive quantification of IL-12 has not previously been performed in large rheumatoid arthritis (RA) cohorts, mainly due to the limited availability and high cost of these platforms. In the present study, we measured serum IL-12 using an ultrasensitive assay to systematically assess its relationship with key disease characteristics in a large, well-characterized cohort of patients with RA.
Methods
A total of 216 patients with RA were recruited and underwent a comprehensive assessment of disease characteristics and disease activity. Lipid parameters and hematological markers were assessed, insulin resistance indices were calculated, and metabolic syndrome was defined according to established criteria. Arterial stiffness, carotid intima-media thickness, and plaque presence were evaluated through carotid ultrasonography. Serum IL-12 levels were quantified using Simoa (Single Molecule Array) technology. To examine the relationship between clinical and metabolic parameters and IL-12 concentrations, multivariable linear regression models were applied.
Results
In multivariable analyses, serum IL-12 levels were independently associated with IFN-γ and rheumatoid factor positivity. However, no significant relationships were found between IL-12 and disease activity indices, acute-phase reactants, cardiovascular risk factors, subclinical atherosclerosis, lipid profile, glucose metabolism, or hematological parameters.
Conclusions
Using an ultrasensitive assay, we found that serum IL-12 levels were associated with interferon-γ levels and rheumatoid factor positivity in patients with RA, supporting a role for IL-12 at the interface between cellular and humoral immunity. In contrast, circulating IL-12 did not appear to be a useful systemic biomarker of disease activity or of the cardiovascular and hematological comorbidities associated with RA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of La Laguna (ULL), 38071 Tenerife, Spain.
- Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
- Instituto de Investigación Sanitaria de Canarias (IISC), 38320 Tenerife, Spain.
- Division of Rheumatology, Hospital Doctor Negrín, 35010 Las Palmas de Gran Canaria, Spain.
- Department of Immunology, Hospital Ramón y Cajal, 28034 Madrid, Spain.
- Department of Immunology, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVA), 39008 Santander, Spain.
ORCID-Profile: Iván Ferraz-Amaro, Juan Carlos Quevedo-Abeledo, Enrique García-Barrera, Luisa María Villar, Javier Gonzalo Ocejo-Vinyals, Miguel Ángel González-Gay
Förderung
- Instituto de Salud Carlos III
- Spanish Red de Investigación RICORS
- European Union
- Ministry of Health
- Spanish Red de Investigación
- Spanish Ministry of Health, Instituto de Salud Carlos III
Zitieren
APA
Ferraz-Amaro, I., Quevedo-Abeledo, J. C., García-Barrera, E., Villar, L. M., Ocejo-Vinyals, J. G., & González-Gay, M. Á. (2026). Interleukin-12 Is Associated with Rheumatoid Factor and Interferon-γ, but Not with Disease Activity, in Patients with Rheumatoid Arthritis. Diagnostics, 16(21), 3643. https://doi.org/10.3390/diagnostics16213643
Vancouver
Ferraz-Amaro I, Quevedo-Abeledo JC, García-Barrera E, Villar LM, Ocejo-Vinyals JG, González-Gay MÁ. Interleukin-12 Is Associated with Rheumatoid Factor and Interferon-γ, but Not with Disease Activity, in Patients with Rheumatoid Arthritis. Diagnostics. 2026;16(21):3643. doi:10.3390/diagnostics16213643
BibTeX
@article{FerrazAmaro2026,
author = {Ferraz-Amaro, Iván and Quevedo-Abeledo, Juan Carlos and García-Barrera, Enrique and Villar, Luisa María and Ocejo-Vinyals, Javier Gonzalo and González-Gay, Miguel Ángel},
title = {Interleukin-12 Is Associated with Rheumatoid Factor and Interferon-γ, but Not with Disease Activity, in Patients with Rheumatoid Arthritis},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {21},
pages = {3643},
doi = {10.3390/diagnostics16213643}
}
EUVIMED